FCRX R&D to Revenue

Crescent Capital BDC, Inc. 5.00% Notes due 2026 · R&D to Revenue

FCRX logo

FCRX R&D to Revenue

Latest reported0.00%
FCRX FY R&D/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

FCRX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Crescent Capital BDC, Inc. 5.00% Notes due 2026 R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.